The Social Life of Rare Disorders

This book is the first comprehensive study of rare disorders from a historical, political, and social perspective. It is estimated that around 300 million people worldwide live with a rare disorder today. What do patients and associations concerned by one of the 7,000 known rare diseases have in common, and what does rarity mean to them? How did rare disorders become a mainstream category in public health policy? To answer these questions, Caroline Huyard traces the history, over more than 50 years, of medical treatments for one particular disease, and that of the orphan drug status in the United States and in Europe.

The book shows that public authorities had a much greater role than biomedicine in turning rare disorders into a public health problem. A comparison of patients' experiences of 6 rare diseases as well as the activities of 8 associations in France underlines the importance of isolation and care for patients on the one hand, and the role of stakeholders' participation for associations on the other hand. This book is essential reading for researchers and students interested in contemporary healthcare systems and topics related to public policies on emerging issues, the industrialisation and regulation of medicine, the concept of care, and the governance of patient organisations.

The first comprehensive study of rare disorders from a social science perspective Sheds light on both the history of rare diseases and on patients' individual and collective experiences Interrogates the idea of rarity in contemporary medicine and beyond

Autorentext

Caroline Huyard is a sociologist. She is a tenured researcher (Chargée de Recherches) at the Centre National de la Recherche Scientifique (CNRS) and the University of Lille, in France.

Inhalt

Introduction.- Part I Birth of the Rare Diseases.- Wilson's Disease: Between Craftsmanlike and Industrial Medicine.- The Invention of Rare Diseases: Responding to the Problem of Orphan Drugs.- Part II What Does It Mean to Experience a Rare Disease?.- Experiencing Isolation.- Association as a Way Out of Isolation?.- Part III Small Groups, Big Challenges.- Who Runs the Associations? Beyond the PatientDoctor Divide.- Building a Therapeutic Toolbox.- A Fragile Coalition of Disparate Associations.- Conclusion.